0.9% sodium chloride, Lepodisiran
J3L-MC-EZEF
Phase 3 small_molecule active
Quick answer
0.9% sodium chloride, Lepodisiran for Atherosclerotic Cardiovascular Disease Elevated lp(a) is a Phase 3 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Atherosclerotic Cardiovascular Disease Elevated lp(a)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active